Cancer Research Donn Young  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 3761-3766, June 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lock, R. B.
Right arrow Articles by Ross, W. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lock, R. B.
Right arrow Articles by Ross, W. E.

Inhibition of p34cdc2 Kinase Activity by Etoposide or Irradiation as a Mechanism of G2 Arrest in Chinese Hamster Ovary Cells1

Richard B. Lock2 and Warren E. Ross3

The J. Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40292

The mammalian homologue of the yeast cdc2 gene product, p34cdc2, is a cell cycle-regulated protein essential for mitosis. We have used polyclonal antisera raised against a peptide corresponding to the carboxyl terminus of the sequence of human cdc2 to study p34cdc2 in Chinese hamster ovary (CHO) cells. Major bands are immunoprecipitated at a molecular weight of 34,000, although not in the presence of competing antigenic peptide. p34cdc2 is coimmunoprecipitated with proteins of molecular weights of 52,000 and 57,000. Immunoprecipitates express histone H1 kinase activity which varies throughout the cell cycle, maximal activity being observed in G2-M. The activity of the p34cdc2 kinase varies according to its association with the Mr 52,000 and 57,000 proteins and according to their phosphorylation state. Treatment of either asynchronous CHO cells or an enriched G2 population with the antitumor agent, etoposide, results in rapid inhibition of immunoprecipitated p34cdc2 kinase activity, which is not due to a direct effect of drug upon the enzyme. p34cdc2 kinase activity recovers as cells arrest in G2 and a second etoposide treatment further inhibits p34cdc2 kinase activity and prolongs G2 arrest. Exposure of asynchronous CHO cells to {gamma}-irradiation also inhibits p34cdc2 kinase activity within 1 h. Again this activity recovers as cells accumulate in G2. These results suggest that DNA damage in CHO cells elicits a response which results in inhibition of p34cdc2 kinase activity and, consequently, G2 arrest.

1 This work was supported by funds from the NIH (USPHS Grant CA-24586).

2 To whom requests for reprints should be addressed.

3 Present address: The College of Medicine, University of Florida, Gainesville, FL 32610.

Received 10/18/89. Revised 2/14/90.


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. J. Mistry and G. F. Atweh
Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer
Mol. Cancer Ther., December 1, 2006; 5(12): 3248 - 3257.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C. A. Andrews, A. C. Vas, B. Meier, J. F. Gimenez-Abian, L. A. Diaz-Martinez, J. Green, S. L. Erickson, K. E. VanderWaal, W.-S. Hsu, and D. J. Clarke
A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin.
Genes & Dev., May 1, 2006; 20(9): 1162 - 1174.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
X. Lu, J. i. Jung, H. J. Cho, D. Y. Lim, H. S. Lee, H. S. Chun, D. Y. Kwon, and J. H. Park
Fisetin Inhibits the Activities of Cyclin-Dependent Kinases Leading to Cell Cycle Arrest in HT-29 Human Colon Cancer Cells
J. Nutr., December 1, 2005; 135(12): 2884 - 2890.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. W. Freie, S. L. M. Ciccone, X. Li, P. A. Plett, C. M. Orschell, E. F. Srour, H. Hanenberg, D. Schindler, S.-H. Lee, and D. W. Clapp
A Role for the Fanconi Anemia C Protein in Maintaining the DNA Damage-induced G2 Checkpoint
J. Biol. Chem., December 3, 2004; 279(49): 50986 - 50993.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
F. Cortes and N. Pastor
Induction of endoreduplication by topoisomerase II catalytic inhibitors
Mutagenesis, March 1, 2003; 18(2): 105 - 112.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Zhao, M. R. Spitz, G. E. Tomlinson, H. Zhang, J. D. Minna, and X. Wu
{gamma}-Radiation-induced G2 Delay, Apoptosis, and p53 Response as Potential Susceptibility Markers For Lung Cancer
Cancer Res., November 1, 2001; 61(21): 7819 - 7824.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Yan, J. E. Schupp, H.-s. Hwang, M. W. Wagner, S. E. Berry, S. Strickfaden, M. L. Veigl, W. D. Sedwick, D. A. Boothman, and T. J. Kinsella
Loss of DNA Mismatch Repair Imparts Defective cdc2 Signaling and G2 Arrest Responses without Altering Survival after Ionizing Radiation
Cancer Res., November 1, 2001; 61(22): 8290 - 8297.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Wang, C. H. McGowan, M. Zhao, L. He, J. S. Downey, C. Fearns, Y. Wang, S. Huang, and J. Han
Involvement of the MKK6-p38gamma Cascade in gamma -Radiation-Induced Cell Cycle Arrest
Mol. Cell. Biol., July 1, 2000; 20(13): 4543 - 4552.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. Stiewe, K. Parssanedjad, H. Esche, B. Opalka, and B. M. Pützer
E1A Overcomes the Apoptosis Block in BCR-ABL+ Leukemia Cells and Renders Cells Susceptible to Induction of Apoptosis by Chemotherapeutic Agents
Cancer Res., July 1, 2000; 60(14): 3957 - 3964.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J.-M. Darbon, M. Penary, N. Escalas, F. Casagrande, F. Goubin-Gramatica, C. Baudouin, and B. Ducommun
Distinct Chk2 Activation Pathways Are Triggered by Genistein and DNA-damaging Agents in Human Melanoma Cells
J. Biol. Chem., May 12, 2000; 275(20): 15363 - 15369.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. D. Kao, W. G. McKenna, and R. J. Muschel
p34Cdc2 Kinase Activity Is Excluded from the Nucleus during the Radiation-induced G2 Arrest in HeLa Cells
J. Biol. Chem., December 3, 1999; 274(49): 34779 - 34784.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
L. E. Harrison, Q. M. Wang, and G. P. Studzinski
Butyrate-Induced G2/M Block in Caco-2 Colon Cancer Cells is Associated with Decreased p34cdc2 Activity
Experimental Biology and Medicine, November 1, 1999; 222(2): 150 - 156.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
H. Barth, M. Klingler, K. Aktories, and V. Kinzel
Clostridium botulinum C2 Toxin Delays Entry into Mitosis and Activation of p34cdc2 Kinase and cdc25-C Phosphatase in HeLa cells
Infect. Immun., October 1, 1999; 67(10): 5083 - 5090.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Whitehouse, P. B. Balbo, E. C. Pesci, D. L. Cottle, P. M. Mirabito, and C. L. Pickett
Campylobacter jejuni Cytolethal Distending Toxin Causes a G2-Phase Cell Cycle Block
Infect. Immun., May 1, 1998; 66(5): 1934 - 1940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. N. Booher, P. S. Holman, and A. Fattaey
Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity
J. Biol. Chem., August 29, 1997; 272(35): 22300 - 22306.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. M. Kupfer, T. Yamashita, D. Naf, A. Suliman, S. Asano, and A. D. D'Andrea
The Fanconi Anemia Polypeptide, FAC, Binds to the Cyclin-Dependent Kinase, cdc2
Blood, August 1, 1997; 90(3): 1047 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J.-M. Hu, J. E. Bodwell, and A. Munck
Control by Basal Phosphorylation of Cell Cycle-Dependent, Hormone-Induced Glucocorticoid Receptor Hyperphosphorylation
Mol. Endocrinol., March 1, 1997; 11(3): 305 - 311.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. M. Uckun, L. Tuel-Ahlgren, K. G. Waddick, X. Jun, J. Jin, D. E. Myers, R. B. Rowley, A. L. Burkhardt, and J. B. Bolen
Physical and Functional Interactions between Lyn and p34[IMAGE] Kinases in Irradiated Human B-cell Precursors
J. Biol. Chem., March 15, 1996; 271(11): 6389 - 6397.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Clarke, R. Johnson, and C. Downes
Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks
J. Cell Sci., January 6, 1993; 105(2): 563 - 569.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.